132 related articles for article (PubMed ID: 35053718)
1. Performance of the EQ-5D-Y Interviewer Administered Version in Young Children.
Amien R; Scott D; Verstraete J
Children (Basel); 2022 Jan; 9(1):. PubMed ID: 35053718
[TBL] [Abstract][Full Text] [Related]
2. The validity and reliability of the interviewer-administered EQ-5D-Y-3L version in young children.
Amien R; Scott D; Verstraete J
Health Qual Life Outcomes; 2023 Feb; 21(1):19. PubMed ID: 36814254
[TBL] [Abstract][Full Text] [Related]
3. How does the EQ-5D-Y Proxy version 1 perform in 3, 4 and 5-year-old children?
Verstraete J; Lloyd A; Scott D; Jelsma J
Health Qual Life Outcomes; 2020 May; 18(1):149. PubMed ID: 32448278
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents.
Verstraete J; Scott D
J Patient Rep Outcomes; 2022 Jun; 6(1):67. PubMed ID: 35708825
[TBL] [Abstract][Full Text] [Related]
5. The performance of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents with cerebral palsy (CP).
Verstraete J; Scott D
Dialogues Health; 2022 Dec; 1():100032. PubMed ID: 38515901
[TBL] [Abstract][Full Text] [Related]
6. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
7. Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers.
Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Busschbach J; Luo N
Eur J Health Econ; 2024 Feb; ():. PubMed ID: 38356007
[TBL] [Abstract][Full Text] [Related]
8. Development of the web-based Spanish and Catalan versions of the Euroqol 5D-Y (EQ-5D-Y) and comparison of results with the paper version.
Robles N; Rajmil L; Rodriguez-Arjona D; Azuara M; Codina F; Raat H; Ravens-Sieberer U; Herdman M
Health Qual Life Outcomes; 2015 Jun; 13():72. PubMed ID: 26037720
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Proxy-Reported EQ-5D-3L-Y and Its Agreement in Self-reported EQ-5D-3L-Y for Patients With Adolescent Idiopathic Scoliosis.
Lin J; Wong CKH; Cheung PWH; Luo N; Cheung JPY
Spine (Phila Pa 1976); 2020 Jul; 45(13):E799-E807. PubMed ID: 32539293
[TBL] [Abstract][Full Text] [Related]
10. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
11. Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.
Mayoral K; Rajmil L; Murillo M; Garin O; Pont A; Alonso J; Bel J; Perez J; Corripio R; Carreras G; Herrero J; Mengibar JM; Rodriguez-Arjona D; Ravens-Sieberer U; Raat H; Serra-Sutton V; Ferrer M
J Med Internet Res; 2019 Nov; 21(11):e14947. PubMed ID: 31714252
[TBL] [Abstract][Full Text] [Related]
12. How do EQ-5D-3L and EQ-5D-5L compare in a Swedish total hip replacement population?
Eneqvist T; Nemes S; Kärrholm J; Burström K; Rolfson O
Acta Orthop; 2020 Jun; 91(3):272-278. PubMed ID: 32237930
[TBL] [Abstract][Full Text] [Related]
13. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
[TBL] [Abstract][Full Text] [Related]
14. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.
Scott D; Ferguson GD; Jelsma J
Health Qual Life Outcomes; 2017 Jan; 15(1):12. PubMed ID: 28103872
[TBL] [Abstract][Full Text] [Related]
15. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
16. Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.
Fang H; Farooq U; Wang D; Yu F; Younus MI; Guo X
Springerplus; 2016; 5(1):1924. PubMed ID: 27917330
[TBL] [Abstract][Full Text] [Related]
17. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.
Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B
Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594
[TBL] [Abstract][Full Text] [Related]
18. [Validity and reliability of the spanish EQ-5D-Y proxy version].
Gusi N; Perez-Sousa MA; Gozalo-Delgado M; Olivares PR
An Pediatr (Barc); 2014 Oct; 81(4):212-9. PubMed ID: 24411558
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
20. A cross sectional survey on health-related quality of life of elementary school students using the Korean version of the EQ-5D-Y.
Kim SK; Jo MW; Kim SH
PeerJ; 2017; 5():e3115. PubMed ID: 28344908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
